Dr Antonio Tedeschi (@tedeschi2020) header
Dr Antonio Tedeschi (@tedeschi2020) profile picture

Principal Scientist I-Laboratory Head @Boehringer/ prev. @TheCrick @IMPvienna /All views my own

Joined March 2020
Photo by Dr Antonio Tedeschi (@tedeschi2020)Photo by Dr Antonio Tedeschi (@tedeschi2020)
Four fantastic months of great science @Boehringer Thanks to the team (Sabine/Conor/Manuel) for their dedication in developing novel and better treatments for cancer patients 👊👨‍🔬👩‍🔬👊
11
Dr Antonio Tedeschi retweeted
Congratulations to @mcandrews_kate @MDAndersonNews for @ScienceTM paper, a collaboration @Boehringer @timheff5 @rkalluriMDPhD An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in #PancreaticCancer science.org/doi/10.1126/scit…
6
2
49
8,956
Dr Antonio Tedeschi retweeted
Excited to share our recent work on the pan-KRAS inhibitors BI-2493 and BI-2865, displaying potent anti-tumor activity in tumors with #KRAS wild-type allele amplification. doi.org/10.1158/1535-7163.MC… Great team effort by team @Boehringer !
22
1
93
6,377
Dr Antonio Tedeschi retweeted
Hot off the press: Our work with #KRASmulti inhibitors suggests novel therapeutic concept for #cancers harboring #KRAS amplifications. Just published by @tedeschi2020 and our team @Boehringer in @MCT_AACR doi.org/10.1158/1535-7163.MC……
13
38
2,724
Dr Antonio Tedeschi retweeted
Exciting progress on targeting #KRAS at #ENASymp24. Outstanding presentations by @Sandra_Misale @cjder23 @DavidHongMD and Jayesh Desai on drugging RAS. Many thanks to @EORTC @theNCI and @AACR for organizing a wonderful meeting in Barcelona. @KRASKickers @Boehringer
2
11
36
3,334
Dr Antonio Tedeschi retweeted
Our MDM2-p53 antagonist showed a manageable safety profile and encouraging signs of efficacy in this @CD_AACR publication from an open-label, first-in-human, Phase Ia/Ib study in people with advanced solid tumors and MDM2 amplification. Further investigations are ongoing. #ASCO23
Just published: The MDM2–p53 Antagonist BI 907828 in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study. bit.ly/3ORQzCK #ASCO23
1
9
31
5,583
Dr Antonio Tedeschi retweeted
The pan-KRAS inhibitors described in this paper (GDP-KRAS inhibitors) are also available as part of a collaborative program through @Boehringer's open innovation portal opnMe.com: opnme.com/collaborate-now/GD….
5
13
2,214
Dr Antonio Tedeschi retweeted
🚨Hot off the press just ahead of #ASCO23. For more on beating #KRAS please see nature.com/articles/d41573-0… at @NatRevDrugDisc
Nature research paper: Pan-KRAS inhibitor disables oncogenic signalling and tumour growth go.nature.com/3N7b7Gn
3
15
4,056
Dr Antonio Tedeschi retweeted
Excited to present and discuss "Therapeutic opportunities targeting oncogenic KRAS beyond KRAS-G12C" at #ENASymp22 @AACR @theNCI @EORTC on October 27. Looking forward to seeing many colleagues in Barcelona. @Boehringer @KRASKickers
Inhibiting KRAS: Past, Present and Future Opportunities— Adrian Gill, Saskia Brachmann, Katrina L. Jackson, and @norbertkraut1 will address this topic in an #AACRCICR Town Hall Meeting at #ENASymp22 (October 26-28, Barcelona, Spain). Learn more: https://nitter.cf/t.co/keGyAnDsW2
3
5
1
21
Dr Antonio Tedeschi retweeted
We condemn the military aggression against Ukraine. We will contribute EUR 2.5 million to humanitarian relief funds for Ukraine and do everything we can to help our impacted colleagues, their families and communities.
11
87
13
543
Dr Antonio Tedeschi retweeted
Was awesome to be a part of a fantastic platform. Urge you to check out and support @catalystinme_
New ! Introducing Fatima Ann Sulaiman ( @FASulaiman2013) consultant at Sulaiman solutions and previous head of research at Blood Cancer UK. Read more: thecatalystinme.com/single-p… #consulting #lifesciencecareers #CancerResearch
2
4
Dr Antonio Tedeschi retweeted
#Postdoc WANTED. We are looking for an enthusiastic scientist, interested in #immune-#oncology and #metabolism, willing to apply 3Dspatial transcriptomics and other state-of-art approaches to find new treatments for cancers. Apply to the link below or drop me an email.Please RT
3
62
4
114
This sounds a very interesting project.
This Post is from an account that no longer exists. Learn more
1
Jan-Michael Peters has an opening in his lab as part of our VIP2 postdoctoral fellowship program. Check out our website for further details: training.vbc.ac.at/post-docs… @ERC_Research @IMPvienna @IMBA_Vienna @gmivienna @MaxPerutzLabs #GenomeArchitecture #LoopExtrusion #Cohesin
6
10
Dr Antonio Tedeschi retweeted
Jan's lab is among the leading in a rapidly moving & exciting field. For basics, check his @ibiology talk (youtube.com/watch?v=ckFS9Wr3…), for a recent review, see nature.com/articles/s41580-0…. A chance for a triple-fit PhD post: hot field, outstanding lab, brilliant (and very kind!) PI.
The Peters lab @IMPvienna is offering a position in the current call of the Vienna BioCenter PhD Program. Check our website for more information on Jan's research. #GenomeArchitecture #LoopExtrusion #Cohesin #CTCF vbcphd.at @univienna @MedUni_Wien
5
9
The Peters lab @IMPvienna is offering a position in the current call of the Vienna BioCenter PhD Program. Check our website for more information on Jan's research. #GenomeArchitecture #LoopExtrusion #Cohesin #CTCF vbcphd.at @univienna @MedUni_Wien
2
6
Dr Antonio Tedeschi retweeted
We are hiring! The @viennabiocenter PhD Program has opened its spring call. Apply to one of Europe's leading #PhD schools by 15 April!
The Vienna BioCenter PhD Program has 17 open positions in the summer call which has just opened for applications. Check out our website for more information about these exciting projects! @IMPvienna @IMBA_Vienna @gmivienna @MaxPerutzLabs @univienna @MedUni_Wien @viennabiocenter
8
8
Dr Antonio Tedeschi retweeted
Applications for currently advertised group leader positions are accepted until 15 February...
Looking at our campaign for #WomenInScience Day, one can see that female PIs are underrepresented @IMPvienna. Shout-out to female postdocs: our current call for a GROUP LEADER POSITION is an opportunity to raise women at our faculty. imp.ac.at/career/group-leade…
10
7
Dr Antonio Tedeschi retweeted
Our heart made it to the cover of @NatureProtocols!! 💓 FLASH #TissueClearing and IF. Nerves (TH) in yellow and ECM (ColIV) in blue. nature.com/nprot/volumes/16/…
3
15
1
107